In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

Victoza is one of the first GLP-1 drugs — the class of wildly popular diabetes and obesity treatments that includes Ozempic ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

Discover the weight loss benefits of semaglutide and liraglutide for obese patients. Cleveland Clinic study examines Wegovy, Ozempic, Saxenda and Victoza.

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Novo Nordisk's liraglutide has been approved for children who are at least 12 years old. However, the drug is now being ...

Children aged between six and 12 saw their BMI fall by 7.4 per cent in a trial which researchers say could offer ...

In a late-stage clinical trial, a drug similar to Ozempic was shown to reduce body mass index in kids ages 6 to 11 with ...